Biofrontera (BFRI) EBITDA Margin (2020 - 2026)
Biofrontera (BFRI) posted quarterly EBITDA Margin of 26.66% for Q4 2025, up 4029.0% year-over-year from 0.65% in Q4 2024, and up 129.68% quarter-over-quarter from 89.84% in Q3 2025.
Biofrontera (BFRI) EBITDA Margin (2020 - 2026) Analysis & Trends
Biofrontera's EBITDA Margin history runs 6 years deep, the most recent figure standing at 26.66% for Q4 2025.
- In Q4 2025, EBITDA Margin rose 4029.0% year-over-year to 26.66%; the TTM figure through Dec 2025 stood at 27.2% (up 1891.0% YoY), while the FY2025 annual figure was 27.21%, up 1890.0% from the prior year.
- EBITDA Margin for Q4 2025 stood at 26.66%, up from 89.84% in the prior quarter.
- The five-year high for EBITDA Margin was 26.66% in Q4 2025, with the low at 371.6% in Q3 2021.
- The 5-year median for EBITDA Margin is 59.57% (2023), against an average of 74.05%.
- The sharpest annual moves came in 2021 and 2022: EBITDA Margin tumbled 29952 bps in 2021, then surged 28740 bps in 2022.
- Biofrontera's EBITDA Margin stood at 12.78% in 2021, then sank by 531 bps to 55.02% in 2022, then surged by 34 bps to 36.48% in 2023, then jumped by 63 bps to 13.63% in 2024, then jumped by 296 bps to 26.66% in 2025.
- Business Quant data shows BFRI's EBITDA Margin at 26.66% in Q4 2025, 89.84% in Q3 2025, and 56.25% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.87 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 32.47 Bn | 30.79 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.38 Bn | 19.71 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.90 Bn | 11.37 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Biofrontera | 19.10 Mn | 14.39 Mn | 9.59 Mn | -4.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.37% |
| Dec 31, 2025 | 26.66% |
| Sep 30, 2025 | -89.84% |
| Jun 30, 2025 | -56.25% |
| Mar 31, 2025 | -52.95% |
| Dec 31, 2024 | -13.63% |
| Sep 30, 2024 | -55.04% |
| Jun 30, 2024 | -64.69% |
| Mar 31, 2024 | -69.10% |
| Dec 31, 2023 | -36.48% |
| Sep 30, 2023 | -51.93% |
| Jun 30, 2023 | -148.75% |
| Mar 31, 2023 | -62.89% |
| Dec 31, 2022 | -55.02% |
| Sep 30, 2022 | -84.20% |
| Jun 30, 2022 | -139.38% |
| Mar 31, 2022 | -31.89% |
| Dec 31, 2021 | 12.78% |
| Sep 30, 2021 | -371.60% |
| Jun 30, 2021 | -62.97% |